Table 4.
DAT immunoreactivity in the Acb and dorsal STR 3 d after a 5 d treatment with cocaine and/or the selective κ-opioid receptor agonist U-69593
| Treatment | Acb | Dorsal STR | n |
|---|---|---|---|
| U-69593 | 112 ± 11 | 95 ± 3 | 6 |
| Cocaine | 132 ± 22 | 129 ± 14 | 6 |
| Vehicle + U-69593 | 186 ± 304-150 | 112 ± 13 | 6 |
Data expressed as percentage of control immunoreactivity ± SEM.
F4-150: p < 0.05 different from controls by one-way ANOVA.